Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Waldenstrom Macroglobulinemia Treatment Options: Alkylators Are Recommended for Primary Therapy, PFS Was Significantly Higher for Ibrutinib + Rituximab vs. Rituximab (iNNOVATE Trial)

0 views
November 19, 2019
Comments 1
Login to view comments. Click here to Login